Literature DB >> 16032586

Differential block of N-propyl derivatives of amitriptyline and doxepin for sciatic nerve block in rats.

Peter Gerner1, Shi Hua Luo, Zhi-Ye Zhuang, Alimorad G Djalali, Anthony M Zizza, Robert R Myers, Ging Kuo Wang.   

Abstract

BACKGROUND AND OBJECTIVES: The propyl group of ropivacaine ( N -propyl-2',6'-pipecoloxylidide hydrochloride) could be responsible for conferring some sensory selectivity to this drug. Thus, adding a propyl group to experimental local anesthetics (LAs) (e.g., the tricyclic antidepressants amitriptyline and doxepin) to increase sensory selectivity may be useful. We, therefore, synthesized N -propyl amitriptyline and N -propyl doxepin and investigated a potential predominance of sensory/nociceptive block over motor block (differential block) in a rat sciatic nerve block model. In addition, tetrodotoxin (TTX), a naturally occuring Na + channel blocker, was coinjected to investigate whether it increased block duration.
METHODS: A 0.2-mL test dose of N -propyl amitriptyline and N -propyl doxepin, at a concentration of 1, 2.5, 5, and 10 mM, (alone or in combination with TTX at a concentration of 20 microM) was injected by the subfascial sciatic nerve approach. Motor function and sensory function (nociception) were evaluated by the force a rat's hind limb produced when pushing against a balance and the reaction to pinch, respectively.
RESULTS: N -propyl amitriptyline and N -propyl doxepin demonstrated prolonged block duration, with N -propyl amitriptyline displaying significant differential block at higher concentrations (5 and 10 mM). The combination of either of these drugs with TTX increased the potency as well as the efficacy. Neurotoxicity commenced at concentrations of 5 to 10 mM.
CONCLUSIONS: Detailed histopathologic nerve toxicity evaluations are justified to determine whether N -propyl amitriptyline has potential as a more sensory-selective local anesthetic at lower concentrations or as a predominantly sensory-selective neurolytic agent at higher concentrations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16032586     DOI: 10.1016/j.rapm.2005.04.008

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  4 in total

1.  Median Effective Concentration of Ropivacaine for Femoral Nerve Block Maintaining Motor Function During Knee Arthroscopy in Two Age Groups.

Authors:  Yan-Lei Tai; Li Peng; Ying Wang; Zi-Jun Zhao; Ya-Nan Li; Chun-Ping Yin; Zhi-Yong Hou; De-Cheng Shao; Ya-Hui Zhang; Qiu-Jun Wang
Journal:  J Pain Res       Date:  2022-06-07       Impact factor: 2.832

2.  Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat.

Authors:  Chad M Brummett; Amrita K Padda; Francesco S Amodeo; Kathleen B Welch; Ralph Lydic
Journal:  Anesthesiology       Date:  2009-11       Impact factor: 7.892

3.  Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat.

Authors:  Chad M Brummett; Mary A Norat; John M Palmisano; Ralph Lydic
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

4.  Effects of perineural administration of dexmedetomidine in combination with levobupivacaine in a rat sciatic nerve block.

Authors:  Mehmet Ali Erdogan; Alaaddin Polat; Aytac Yucel; Mustafa Said Aydogan; Hakan Parlakpinar; Suat Tekin; Mahmut Durmus; Mehmet Ozcan Ersoy
Journal:  Curr Ther Res Clin Exp       Date:  2013-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.